Baltimore’s MIRA Pharmaceuticals raises $8.9 million from IPO

Executives for a Baltimore cannabis pharmaceutical company rang the opening bell on the Nasdaq Exchange on Wednesday, two days after closing the company’s nearly $9 million initial public offering. The biggest surprise of the day for CEO Erez Aminov was that ringing the bell to open the day of stock trading didn’t even involve a bell. “It’s a touchscreen,” Aminov said. “I’m not even in control of ringing the bell.”